+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Osteoarthritis Therapeutics Market by Treatment Type, Disease Stage, Route of Administration, End-User, Distribution Channel - Global Forecast to 2030- Product Image
Osteoarthritis Therapeutics Market by Treatment Type, Disease Stage, Route of Administration, End-User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Osteoarthritis Therapeutics Market by Treatment Type, Disease Stage, Route of Administration, End-User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 184 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 5674401
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The Osteoarthritis Therapeutics Market is evolving rapidly as industry leaders seek to address growing clinical and economic pressures worldwide. Companies operating in this sector face complex challenges, from therapeutic innovation to global regulatory shifts. This summary highlights the landscape of opportunities and risks suited to senior decision-makers.

Market Snapshot: Osteoarthritis Therapeutics Market Overview

The Osteoarthritis Therapeutics Market grew from USD 5.17 billion in 2024 to USD 5.55 billion in 2025. It is projected to continue expanding at a CAGR of 7.49%, with expectations of reaching USD 7.98 billion by 2030. Growth is driven by rising demand for effective pain management, an increasing global burden of osteoarthritis, and a continuous stream of therapeutic and technological advancements.

Scope & Segmentation

This research report provides a granular examination of market drivers, patient needs, innovation trends, and regulatory dynamics across multiple segmentation points:

  • Treatment Types: Complementary therapies (acupuncture, massage therapy, nutritional supplements), drug therapies (corticosteroid injections, hyaluronic acid injections, non-steroidal anti-inflammatory drugs, opioids), physical therapy, and surgery (arthroscopy, joint replacement, osteotomy procedures: femoral and tibial osteotomy).
  • Disease Stages: Advanced, early, and moderate stage interventions, categorizing patient needs by severity and corresponding care solutions.
  • Routes of Administration: Injectable, oral, topical, and transdermal formats for therapy delivery, shaping patient adherence and outcomes.
  • End-User Settings: Clinics, hospitals, and rehabilitation centers, reflecting acute and long-term patient management strategies.
  • Distribution Channels: Hospital pharmacies, online pharmacies, and retail pharmacies, essential for optimizing supply chain effectiveness.
  • Regions Covered: Americas (including United States by major states, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (with detailed country coverage), and Asia-Pacific (focusing on key economies and healthcare growth areas).
  • Key Players: Major market participants include AbbVie Inc., Amgen Inc., Anika Therapeutics, AstraZeneca PLC, Bayer AG, Boehringer Ingelheim, Cipla Ltd., Doron Therapeutics, Eli Lilly and Company, Endo International, Ferring B.V., Fidia Farmaceutici, GlaxoSmithKline PLC, Hanmi Pharm, Hikma Pharmaceuticals, Johnson & Johnson, Kitov Pharmaceuticals, Mallinckrodt Pharmaceuticals, Merck & Co., Pacira BioSciences, Pfizer Inc., Sanofi S.A., Sun Pharmaceutical Industries, Takeda Pharmaceutical, Teva Pharmaceutical, UCB S.A., and Viatris Inc.

Key Takeaways for Senior Decision-Makers

  • Precision medicine and patient-centric care models are increasingly informing product development and delivery, offering more tailored and effective outcomes across multiple disease stages.
  • Advances in biologics, regenerative therapies, and digital health platforms are reshaping traditional treatment paradigms and supporting adherence through remote monitoring and analytics.
  • Minimally invasive surgical robotics and next-generation joint implants are reducing recovery times and enhancing procedural accuracy, raising the competitive standard for device manufacturers.
  • Value-based care and outcome-driven reimbursement models are encouraging providers, payers, and manufacturers to collaborate on demonstrating quantifiable health improvements rather than focusing on service volume.
  • Agility in supply chain and technology adoption is critical, particularly as new business models and partnership approaches emerge across developed and developing regions.

Tariff Impact: Navigating Cost and Access Constraints

  • Implementation of United States tariffs has increased the cost of imported raw materials for essential therapeutics and orthopedic devices, prompting manufacturers to reconsider global sourcing and production networks.
  • In response to increased tariffs, industry participants are strengthening local and regional manufacturing agreements, renegotiating supplier terms, and adopting lean production processes to offset potential margin pressures.
  • Healthcare providers are adapting procurement practices, emphasizing high-value interventions and group purchasing strategies to maintain patient access in a changing cost environment.

Methodology & Data Sources

Findings are built on comprehensive secondary research, integrated with primary insights from interviews with clinical specialists and industry executives. In-depth literature reviews, triangulated quantitative validation, and rigorous peer review underlie the analysis to ensure data robustness and relevance.

Why This Report Matters

  • Enables decision-makers to identify emerging market risks and opportunities driven by patient trends, technological innovation, and policy shifts.
  • Provides segmentation insights that support targeted strategic planning, product portfolio optimization, and improved market positioning.
  • Delivers actionable intelligence for resource allocation, supply chain resilience, and collaborative growth strategies in a dynamic global market.

Conclusion

This executive summary delivers an actionable overview of the osteoarthritis therapeutics landscape, empowering stakeholders to drive innovation, operational agility, and market success through informed decision-making.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Osteoarthritis Therapeutics Market, by Treatment Type
8.1. Introduction
8.2. Complementary Therapies
8.2.1. Acupuncture
8.2.2. Massage Therapy
8.2.3. Nutritional Supplements
8.3. Drug Therapy
8.3.1. Corticosteroid Injections
8.3.2. Hyaluronic Acid Injections
8.3.3. Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)
8.3.4. Opioids
8.4. Physical Therapy
8.5. Surgery
8.5.1. Arthroscopy
8.5.2. Joint Replacement
8.5.3. Osteotomy
8.5.3.1. Femoral Osteotomy
8.5.3.2. Tibial Osteotomy
9. Osteoarthritis Therapeutics Market, by Disease Stage
9.1. Introduction
9.2. Advanced Stage
9.3. Early Stage
9.4. Moderate Stage
10. Osteoarthritis Therapeutics Market, by Route of Administration
10.1. Introduction
10.2. Injectable
10.3. Oral
10.4. Topical
10.5. Transdermal
11. Osteoarthritis Therapeutics Market, by End-User
11.1. Introduction
11.2. Clinics
11.3. Hospitals
11.4. Rehabilitation Centers
12. Osteoarthritis Therapeutics Market, by Distribution Channel
12.1. Introduction
12.2. Hospital Pharmacies
12.3. Online Pharmacies
12.4. Retail Pharmacies
13. Americas Osteoarthritis Therapeutics Market
13.1. Introduction
13.2. United States
13.3. Canada
13.4. Mexico
13.5. Brazil
13.6. Argentina
14. Europe, Middle East & Africa Osteoarthritis Therapeutics Market
14.1. Introduction
14.2. United Kingdom
14.3. Germany
14.4. France
14.5. Russia
14.6. Italy
14.7. Spain
14.8. United Arab Emirates
14.9. Saudi Arabia
14.10. South Africa
14.11. Denmark
14.12. Netherlands
14.13. Qatar
14.14. Finland
14.15. Sweden
14.16. Nigeria
14.17. Egypt
14.18. Turkey
14.19. Israel
14.20. Norway
14.21. Poland
14.22. Switzerland
15. Asia-Pacific Osteoarthritis Therapeutics Market
15.1. Introduction
15.2. China
15.3. India
15.4. Japan
15.5. Australia
15.6. South Korea
15.7. Indonesia
15.8. Thailand
15.9. Philippines
15.10. Malaysia
15.11. Singapore
15.12. Vietnam
15.13. Taiwan
16. Competitive Landscape
16.1. Market Share Analysis, 2024
16.2. FPNV Positioning Matrix, 2024
16.3. Competitive Analysis
16.3.1. AbbVie Inc.
16.3.2. Amgen Inc.
16.3.3. Anika Therapeutics, Inc.
16.3.4. AstraZeneca PLC
16.3.5. Bayer AG
16.3.6. Boehringer Ingelheim International GmbH
16.3.7. Cipla Ltd.
16.3.8. Doron Therapeutics
16.3.9. Eli Lilly and Company
16.3.10. Endo International plc
16.3.11. Ferring B.V.
16.3.12. Fidia Farmaceutici S.p.A
16.3.13. GlaxoSmithKline PLC
16.3.14. Hanmi Pharm. Co., Ltd.
16.3.15. Hikma Pharmaceuticals PLC
16.3.16. Johnson & Johnson Services Inc.
16.3.17. Kitov Pharmaceuticals Ltd.
16.3.18. Mallinckrodt Pharmaceuticals
16.3.19. Merck & Co.
16.3.20. Pacira BioSciences, Inc.
16.3.21. Pfizer Inc.
16.3.22. Sanofi S.A.
16.3.23. Sun Pharmaceutical Industries Ltd.
16.3.24. Takeda Pharmaceutical Company
16.3.25. Teva Pharmaceutical Industries Ltd.
16.3.26. UCB S.A.
16.3.27. Viatris Inc.
17. ResearchAI
18. ResearchStatistics
19. ResearchContacts
20. ResearchArticles
21. Appendix
List of Figures
FIGURE 1. OSTEOARTHRITIS THERAPEUTICS MARKET MULTI-CURRENCY
FIGURE 2. OSTEOARTHRITIS THERAPEUTICS MARKET MULTI-LANGUAGE
FIGURE 3. OSTEOARTHRITIS THERAPEUTICS MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2024 VS 2030 (%)
FIGURE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2030 (%)
FIGURE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 18. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 20. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 24. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 25. OSTEOARTHRITIS THERAPEUTICS MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 26. OSTEOARTHRITIS THERAPEUTICS MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. OSTEOARTHRITIS THERAPEUTICS MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ACUPUNCTURE, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY MASSAGE THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NUTRITIONAL SUPPLEMENTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CORTICOSTEROID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HYALURONIC ACID INJECTIONS, BY REGION, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY NON-STEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDS), BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY PHYSICAL THERAPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ARTHROSCOPY, BY REGION, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY JOINT REPLACEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY FEMORAL OSTEOTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TIBIAL OSTEOTOMY, BY REGION, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ADVANCED STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY EARLY STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY MODERATE STAGE, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TRANSDERMAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY REHABILITATION CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 40. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 41. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY HOSPITAL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 42. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ONLINE PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 43. GLOBAL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY RETAIL PHARMACIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 48. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 49. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 50. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 51. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 52. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 53. AMERICAS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 57. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 58. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 59. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 60. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 61. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 62. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 63. UNITED STATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 64. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 65. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 66. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 67. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 68. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 69. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 70. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 72. CANADA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 75. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 76. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 77. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 78. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 79. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 80. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 81. MEXICO OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 82. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 83. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 84. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 85. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 86. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 87. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 88. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 89. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 90. BRAZIL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 91. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 92. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 93. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 94. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 95. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 96. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 97. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 98. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 99. ARGENTINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 100. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 101. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 102. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 103. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 104. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 105. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 106. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 107. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 108. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 109. EUROPE, MIDDLE EAST & AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 110. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 111. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 112. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 113. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 114. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 115. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 116. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 117. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 118. UNITED KINGDOM OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 119. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 120. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 121. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 122. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 123. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 124. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 125. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 126. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 127. GERMANY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 128. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 129. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 130. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 131. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 132. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 133. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 134. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 135. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 136. FRANCE OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 137. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 138. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 139. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 140. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 141. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 142. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 143. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 145. RUSSIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 148. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 149. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 150. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 151. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 152. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 153. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 154. ITALY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 155. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 156. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 157. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 158. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 159. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 160. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 161. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 162. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 163. SPAIN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 164. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 165. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 166. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 167. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 168. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 169. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 170. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 171. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 172. UNITED ARAB EMIRATES OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 173. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 174. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 175. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 176. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 177. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 178. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 179. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 180. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 181. SAUDI ARABIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 182. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 183. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 184. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 185. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 186. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 187. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 188. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 189. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 190. SOUTH AFRICA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 191. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 192. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 193. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 194. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 195. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 196. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 197. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 198. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 199. DENMARK OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 200. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 201. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 202. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 203. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 204. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 205. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 206. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 207. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 208. NETHERLANDS OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 209. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 210. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 211. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 212. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 213. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 214. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 215. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 217. QATAR OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 220. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 221. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 222. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 223. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 224. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 225. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 226. FINLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 227. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 228. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 229. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 230. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 231. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 232. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 233. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 234. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 235. SWEDEN OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 236. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 237. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 238. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 239. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 240. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 241. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 242. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 243. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 244. NIGERIA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 245. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 246. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 247. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 248. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 249. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 250. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 251. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 252. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 253. EGYPT OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 254. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 255. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 256. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 257. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 258. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 259. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 260. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 261. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 262. TURKEY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 263. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 264. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 265. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 266. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 267. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 268. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 269. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 270. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 271. ISRAEL OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 272. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 273. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 274. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 275. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 276. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 277. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 278. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 279. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 280. NORWAY OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 281. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 282. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 283. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 284. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 285. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 286. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 287. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 288. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 289. POLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 290. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 291. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 292. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 293. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 294. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 295. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 296. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 298. SWITZERLAND OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 300. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 301. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 302. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY SURGERY, 2018-2030 (USD MILLION)
TABLE 303. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY OSTEOTOMY, 2018-2030 (USD MILLION)
TABLE 304. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISEASE STAGE, 2018-2030 (USD MILLION)
TABLE 305. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 306. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
TABLE 307. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 308. ASIA-PACIFIC OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 309. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 310. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY COMPLEMENTARY THERAPIES, 2018-2030 (USD MILLION)
TABLE 311. CHINA OSTEOARTHRITIS THERAPEUTICS MARKET SIZE, BY DRUG THERAPY, 2018-2030 (USD MILLION)
TABLE 312. CHINA OSTEOARTHRITIS THERAPEUTICS MARK

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Osteoarthritis Therapeutics market report include:
  • AbbVie Inc.
  • Amgen Inc.
  • Anika Therapeutics, Inc.
  • AstraZeneca PLC
  • Bayer AG
  • Boehringer Ingelheim International GmbH
  • Cipla Ltd.
  • Doron Therapeutics
  • Eli Lilly and Company
  • Endo International plc
  • Ferring B.V.
  • Fidia Farmaceutici S.p.A
  • GlaxoSmithKline PLC
  • Hanmi Pharm. Co., Ltd.
  • Hikma Pharmaceuticals PLC
  • Johnson & Johnson Services Inc.
  • Kitov Pharmaceuticals Ltd.
  • Mallinckrodt Pharmaceuticals
  • Merck & Co.
  • Pacira BioSciences, Inc.
  • Pfizer Inc.
  • Sanofi S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Takeda Pharmaceutical Company
  • Teva Pharmaceutical Industries Ltd.
  • UCB S.A.
  • Viatris Inc.

Table Information

Report AttributeDetails
No. of Pages184
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 5.55 Billion
Forecasted Market Value ( USD ) by 2030 $ 7.98 Billion
Compound Annual Growth Rate7.4%
Regions CoveredGlobal
No. of Companies Mentioned28

Related Topics

Related Reports

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Osteoarthritis Therapeutics Market Size, Share & Trends Analysis Report By Drug Type (NSAIDs, Corticosteroids), By Anatomy (Hip Osteoarthritis), By Route Of Administration (Topical Route, Oral Route), By Sales Channel, By End-use, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Osteoarthritis Pain Drug Market by Product Type, Route of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast to 2030 - Product Image

Osteoarthritis Pain Drug Market by Product Type, Route of Administration, Distribution Channel, End User, Patient Age Group, Disease Severity - Global Forecast to 2030

  • Report
  • 185 Pages
  • Global
From
Osteoarthritis Market Report 2025 - Product Image

Osteoarthritis Market Report 2025

  • Report
  • 200 Pages
  • Global
From
Sodium Hyaluronate Intra-Articular Injection Market by Indication, Product Type, End User, Distribution Channel, Frequency Of Administration - Global Forecast to 2030 - Product Image

Sodium Hyaluronate Intra-Articular Injection Market by Indication, Product Type, End User, Distribution Channel, Frequency Of Administration - Global Forecast to 2030

  • Report
  • 191 Pages
  • Global
From
Osteoarthritis Therapeutics - Global Strategic Business Report - Product Image

Osteoarthritis Therapeutics - Global Strategic Business Report

  • Report
  • 84 Pages
  • Global
From

About the Osteoarthritis Drug Market

The Osteoarthritis Drug market is a subset of the larger Musculoskeletal Disorders Drugs market. Osteoarthritis is a degenerative joint disease that affects millions of people worldwide. It is characterized by the breakdown of cartilage in the joints, leading to pain, stiffness, and decreased mobility. Treatment for osteoarthritis typically involves a combination of lifestyle changes, physical therapy, and medications. Common medications used to treat osteoarthritis include non-steroidal anti-inflammatory drugs (NSAIDs), analgesics, and disease-modifying antirheumatic drugs (DMARDs). The Osteoarthritis Drug market is highly competitive, with a variety of companies offering products to treat the condition. Some of the major players in the market include Pfizer, Merck, Novartis, AbbVie, and Johnson & Johnson. Other companies such as Amgen, Eli Lilly, and Bristol-Myers Squibb also offer products for the treatment of osteoarthritis. Show Less Read more

Copyright © 2002-2025 Research and Markets. All Rights Reserved.